NCT07467811 is a NA clinical trial of 10THERMA in Wrinkles, sponsored by TENTECH INC..

Who is sponsoring NCT07467811?

NCT07467811 is sponsored by TENTECH INC..

What drugs are being tested in NCT07467811?

Interventions in NCT07467811: 10THERMA, Thermage FLX.

Is NCT07467811 still recruiting?

NCT07467811 is currently completed. Last updated 12 March 2026.

Last reviewed 2026-03-12 · How we verify

NCT07467811

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single-Blind, Investigational Device Exemption Paired-Design, Non-Inferiority Trial With Confirmation for the Assessment of the Efficacy and Safety of a Universal Electrosurgical Device for Temporary Improvement of Mild and Moderate Wrinkles Around Both Eye Corners and Both Cheek Folds

Completed NA Last updated 12 March 2026

What this trial tests

NA trial testing 10THERMA in Wrinkles in 80 participants. Completed in 7 January 2025.

Timeline

10 May 2024

Primary endpoint
13 November 2024

7 January 2025

Quick facts

Lead sponsor	TENTECH INC.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	10 May 2024
Primary completion	13 November 2024
Estimated completion	7 January 2025
Sites	3 locations across South Korea

Drugs / interventions tested

10THERMA
Thermage FLX

Conditions studied

Wrinkles — all drugs for Wrinkles →

Sponsor

TENTECH INC. — full company profile →

Who can join

Adults 30 to 65, any sex, with Wrinkles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Radiofrequency (RF) devices are commonly used for noninvasive facial rejuvenation. This study compared the efficacy and safety of 10THERMA, a newly developed monopolar RF device, with those of the Thermage FLX system. To determine whether 10THERMA is noninferior to Thermage FLX in improving mild-to-moderate periorbital and cheek wrinkles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wrinkles

Currently open trials in the same condition.

NCT07495865 — Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2 · recruiting
NCT07111156 — A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wr · NA · active not recruiting
NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07467811 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TENTECH INC.
Last refreshed: 12 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07467811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing